Prevention and Treatment of Viral Infection and Viral Infection-Induced Organ Failure

Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. Th...

Full description

Saved in:
Bibliographic Details
Main Authors MA, JIANJIE, YOUNT, JACOB S, SERMERSHEIM, MATTHEW A, KENNEY, ADAM D, ZHOU, Xinyu, MOKADAM, NAHUSH A, TAN, TAO, CAI, CHUANXI, WHITSON, BRYAN A
Format Patent
LanguageEnglish
Published 14.10.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. The MG53 may also be administered as a composition that expresses and releases MG53 after in vivo administration of said composition to a subject.
Bibliography:Application Number: US202117184781